• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胞饮抗原的颗粒大小会影响交叉呈递途径。

The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen.

机构信息

Cancer Sciences Division, University of Southampton, Southampton, UK.

出版信息

Immunology. 2012 Jun;136(2):163-75. doi: 10.1111/j.1365-2567.2012.03558.x.

DOI:10.1111/j.1365-2567.2012.03558.x
PMID:22260486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3403259/
Abstract

Cross-presentation is the presentation by MHC class I of antigenic peptides from exogenous proteins that have been internalized and processed by professional antigen-presenting cells, e.g. dendritic cells. We have investigated the influence of particle size and antigen load on cross-presentation following antigen delivery on microspheres (MS). Cross-presentation from small particles (0·8-μm) is sensitive to proteasome inhibition and the blockade of endoplasmic reticulum-resident MHC class I complex export, whereas cross-presentation from larger particles (aggregated clumps of 0·8-μm MS) is resistant to these antagonists. This observation may have been overlooked previously, because of the heterogeneity of particle size and MS uptake in unsorted dendritic cell populations. Larger particles carry more antigen, but we show that antigen load does not influence the cross-presentation pathway used. Whereas early endosome autoantigen 1 (EEA1) could be observed in all phagosomes, we observed endoplasmic reticulum SNARE of molecular weight 24 000 (ERS24) and cathepsin S in association with 3·0-μm and aggregated 0·8-μm MS, but not individual 0·8-μm MS. A potential mechanism underlying our observations may be the activation of β-catenin by disruption of E-cadherin-mediated adhesion. Activated β-catenin was detected in the cytoplasm of cells after phagocytosis of MS (highest levels for the largest particles). We propose that particle size can direct the use of different pathways for the cross-presentation of an identical antigen. Furthermore, these pathways have differing yields of MHC class I-peptide complexes, which is an important variable in designing vaccination strategies for maximal antigen expression and CD8(+) T-cell priming.

摘要

交叉呈递是 MHC I 类分子呈递外源性蛋白抗原肽的过程,这些抗原肽已被内吞和加工处理,例如树突状细胞。我们研究了在微球(MS)上递送抗原后,粒径和抗原负载对交叉呈递的影响。小颗粒(0.8μm)的交叉呈递对蛋白酶体抑制和内质网驻留 MHC I 类复合物输出的阻断敏感,而较大颗粒(0.8μm MS 的聚集团块)的交叉呈递则对这些拮抗剂有抗性。这种观察结果以前可能被忽略了,因为在未分选的树突状细胞群体中,颗粒大小和 MS 摄取存在异质性。较大的颗粒携带更多的抗原,但我们表明抗原负载不会影响使用的交叉呈递途径。虽然早期内体自身抗原 1(EEA1)可以在所有吞噬体中观察到,但我们观察到内质网 SNARE 分子量为 24000(ERS24)和组织蛋白酶 S 与 3.0μm 和聚集的 0.8μm MS 相关联,但与单个 0.8μm MS 无关。我们观察结果的潜在机制可能是通过破坏 E-钙黏蛋白介导的粘附来激活β-连环蛋白。在吞噬 MS 后(对于最大的颗粒,水平最高)可以在细胞的细胞质中检测到激活的β-连环蛋白。我们提出,颗粒大小可以指导相同抗原的交叉呈递使用不同的途径。此外,这些途径具有不同的 MHC I 类肽复合物产量,这是设计最大抗原表达和 CD8+T 细胞启动的疫苗接种策略的重要变量。

相似文献

1
The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen.胞饮抗原的颗粒大小会影响交叉呈递途径。
Immunology. 2012 Jun;136(2):163-75. doi: 10.1111/j.1365-2567.2012.03558.x.
2
Impact of the TAP-like transporter in antigen presentation and phagosome maturation.TAP 样转运体在抗原呈递和吞噬体成熟中的作用。
Mol Immunol. 2019 Sep;113:75-86. doi: 10.1016/j.molimm.2018.06.268. Epub 2018 Jun 23.
3
The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells.吞噬体pH值对树突状细胞交叉呈递的大小依赖性效率的作用。
Biomaterials. 2009 Mar;30(7):1356-62. doi: 10.1016/j.biomaterials.2008.11.034. Epub 2008 Dec 16.
4
A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.一种依赖于蛋白酶体、不依赖于 TAP 的胞饮抗原交叉呈递途径。
EMBO Rep. 2011 Dec 1;12(12):1257-64. doi: 10.1038/embor.2011.203.
5
Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments.噬菌体颗粒抗原在MHC II类和内质网标志物阳性区室中的交叉呈递。
Eur J Immunol. 2005 Jul;35(7):2041-50. doi: 10.1002/eji.200425322.
6
Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells.受体介导的吞噬作用可在非专职抗原呈递细胞中引发交叉呈递。
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3324-9. doi: 10.1073/pnas.0813305106. Epub 2009 Feb 13.
7
The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation.抗原从巨噬细胞吞噬体递送至细胞质以进行MHC I类限制性抗原呈递的效率。
Vaccine. 1997 Apr;15(5):511-8. doi: 10.1016/s0264-410x(97)00221-1.
8
Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.通过参与吞噬作用的细胞亚群对源自可溶性外源性抗原的肽进行主要组织相容性复合体I类呈递。
J Exp Med. 1995 Sep 1;182(3):841-51. doi: 10.1084/jem.182.3.841.
9
Cross-presentation: underlying mechanisms and role in immune surveillance.交叉呈递:潜在机制及其在免疫监视中的作用
Immunol Rev. 2005 Oct;207:166-83. doi: 10.1111/j.0105-2896.2005.00301.x.
10
Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.在吞噬作用过程中重定向可溶性抗原以进行MHC I类交叉提呈。
Eur J Immunol. 2015 Feb;45(2):383-95. doi: 10.1002/eji.201445156. Epub 2014 Dec 8.

引用本文的文献

1
Asymmetric Dimethylarginine Disrupts Tumor Antigen Presentation in Breast Cancer.不对称二甲基精氨酸破坏乳腺癌中的肿瘤抗原呈递。
Int J Mol Sci. 2025 May 8;26(10):4482. doi: 10.3390/ijms26104482.
2
Novel Antigen-Presenting Cell-Targeted Nanoparticles Enhance Split Vaccine Immunity Through Microneedles Inoculation.新型靶向抗原呈递细胞的纳米颗粒通过微针接种增强裂解疫苗免疫
Int J Nanomedicine. 2025 Apr 30;20:5529-5549. doi: 10.2147/IJN.S502724. eCollection 2025.
3
Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer.多学科方法为临床有效的癌症肽疫苗铺平道路。
NPJ Vaccines. 2025 Apr 9;10(1):68. doi: 10.1038/s41541-025-01118-9.
4
Engineering customized nanovaccines for enhanced cancer immunotherapy.工程定制纳米疫苗以增强癌症免疫治疗
Bioact Mater. 2024 Mar 10;36:330-357. doi: 10.1016/j.bioactmat.2024.02.028. eCollection 2024 Jun.
5
Therapeutic induction of antigen-specific immune tolerance.抗原特异性免疫耐受的治疗诱导。
Nat Rev Immunol. 2024 May;24(5):338-357. doi: 10.1038/s41577-023-00970-x. Epub 2023 Dec 12.
6
Particle-Based therapies for antigen specific treatment of type 1 diabetes.基于粒子的疗法用于 1 型糖尿病的抗原特异性治疗。
Int J Pharm. 2023 Jan 25;631:122500. doi: 10.1016/j.ijpharm.2022.122500. Epub 2022 Dec 15.
7
The Lack of STING Impairs the MHC-I Dependent Antigen Presentation and JAK/STAT Signaling in Murine Macrophages.STING 缺失会损害小鼠巨噬细胞中 MHC-I 依赖性抗原呈递和 JAK/STAT 信号通路。
Int J Mol Sci. 2022 Nov 17;23(22):14232. doi: 10.3390/ijms232214232.
8
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review.耐受性疫苗中的前沿递送系统和佐剂:综述
Pharmaceutics. 2022 Aug 25;14(9):1782. doi: 10.3390/pharmaceutics14091782.
9
Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.基于纳米颗粒和微粒的针对具有兽医重要性的环状病毒的疫苗
Vaccines (Basel). 2022 Jul 14;10(7):1124. doi: 10.3390/vaccines10071124.
10
Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.了解颗粒的吞噬作用:疫苗和治疗药物合理设计的关键。
Pharm Res. 2022 Aug;39(8):1823-1849. doi: 10.1007/s11095-022-03301-2. Epub 2022 Jun 23.

本文引用的文献

1
Transient assembly of F-actin by phagosomes delays phagosome fusion with lysosomes in cargo-overloaded macrophages.吞噬体介导的F-肌动蛋白瞬时组装会延迟货物过载巨噬细胞中吞噬体与溶酶体的融合。
J Cell Sci. 2009 Aug 15;122(Pt 16):2935-45. doi: 10.1242/jcs.048355. Epub 2009 Jul 28.
2
Issues associated with assessing nuclear localization of N-terminally unphosphorylated beta-catenin with monoclonal antibody 8E7.使用单克隆抗体8E7评估N端未磷酸化β-连环蛋白的核定位相关问题。
Biol Direct. 2009 Feb 2;4:5. doi: 10.1186/1745-6150-4-5.
3
Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC.布雷菲德菌素A抑制静息状态下而非经CpG和破坏激活的树突状细胞中囊泡内主要组织相容性复合体I类分子的加工过程。
Mol Immunol. 2008 Nov;46(1):158-65. doi: 10.1016/j.molimm.2008.07.018. Epub 2008 Aug 23.
4
Rational design of nasal vaccines.鼻用疫苗的合理设计。
J Drug Target. 2008 Jan;16(1):1-17. doi: 10.1080/10611860701637966.
5
The dynamic phagosomal proteome and the contribution of the endoplasmic reticulum.动态吞噬体蛋白质组及内质网的作用
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18520-5. doi: 10.1073/pnas.0705801104. Epub 2007 Nov 15.
6
Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation.E-钙黏蛋白介导的黏附作用的破坏会诱导树突状细胞成熟的一种功能上不同的途径。
Immunity. 2007 Oct;27(4):610-24. doi: 10.1016/j.immuni.2007.08.015. Epub 2007 Oct 11.
7
Wnt signaling and phosphorylation status of beta-catenin: importance of the correct antibody tools.Wnt信号传导与β-连环蛋白的磷酸化状态:正确抗体工具的重要性。
Blood. 2007 Oct 1;110(7):2778-9. doi: 10.1182/blood-2007-05-092445.
8
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.接种疫苗后的1型和2型免疫受纳米颗粒大小影响:呼吸道合胞病毒模型疫苗的配方
Mol Pharm. 2007 Jan-Feb;4(1):73-84. doi: 10.1021/mp060096p.
9
Pathogen recognition and development of particulate vaccines: does size matter?病原体识别与颗粒疫苗的研发:大小重要吗?
Methods. 2006 Sep;40(1):1-9. doi: 10.1016/j.ymeth.2006.05.016.
10
The DRiP hypothesis decennial: support, controversy, refinement and extension.“依赖RNA聚合酶I的蛋白质合成假说”十年回顾:支持、争议、完善与拓展
Trends Immunol. 2006 Aug;27(8):368-73. doi: 10.1016/j.it.2006.06.008. Epub 2006 Jul 11.